DHRS9
Dehydrogenase/reductase SDR family member 9
Also known as: 3alpha-HSD, DHRS9_HUMAN, RDH15, RDHL, RETSDR8, SDR9C4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BPW9
- Gene
- DHRS9
- Ensembl
- ENSG00000073737
- Chromosome
- 2
- Canonical length
- 319 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. This protein demonstrates oxidoreductase activity toward hydroxysteroids and is able to convert 3-alpha-tetrahydroprogesterone to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone in the cytoplasm, and may additionally function as a transcriptional repressor in the nucleus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>Q9BPW9|DHRS9
1 MLFWVLGLLI LCGFLWTRKG KLKIEDITDK YIFITGCDSG FGNLAARTFD KKGFHVIAAC
61 LTESGSTALK AETSERLRTV LLDVTDPENV KRTAQWVKNQ VGEKGLWGLI NNAGVPGVLA
121 PTDWLTLEDY REPIEVNLFG LISVTLNMLP LVKKAQGRVI NVSSVGGRLA IVGGGYTPSK
181 YAVEGFNDSL RRDMKAFGVH VSCIEPGLFK TNLADPVKVI EKKLAIWEQL SPDIKQQYGE
241 GYIEKSLDKL KGNKSYVNMD LSPVVECMDH ALTSLFPKTH YAAGKDAKIF WIPLSHMPAA
301 LQDFLLLKQK AELANPKAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHRS9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- colon: 66 nTPM
- heart muscle: 50 nTPM
- rectum: 43 nTPM
- esophagus: 26 nTPM
- tonsil: 25 nTPM
- lymph node: 19 nTPM
Single-cell type
- syncytiotrophoblasts: 577 nCPM
- esophageal apical cells: 427 nCPM
- colonocytes: 385 nCPM
- respiratory secretory cells: 186 nCPM
- foveolar cells: 162 nCPM
- early spermatids: 159 nCPM
Immune cell
- basophil: 259 nTPM
- eosinophil: 100 nTPM
- neutrophil: 78 nTPM
- intermediate monocyte: 25 nTPM
- myeloid DC: 22 nTPM
- classical monocyte: 21 nTPM
Brain region
- white matter: 7.1 nTPM
- pons: 6.1 nTPM
- medulla oblongata: 6 nTPM
- spinal cord: 5.6 nTPM
- thalamus: 4.3 nTPM
- midbrain: 4.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.62
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.05
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 9-cis-retinoic acid biosynthetic process
- androgen metabolic process
- epithelial cell differentiation
- progesterone metabolic process
- retinol metabolic process
- steroid metabolic process
Molecular functions
- alcohol dehydrogenase (NAD+) activity
- all-trans-retinol dehydrogenase (NAD+) activity
- androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
- androsterone dehydrogenase [NAD(P)+] activity
- oxidoreductase activity
- testosterone dehydrogenase (NAD+) activity
- racemase and epimerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHRS9 as an antibody target. Whether an autoantibody or antibody against DHRS9 could matter depends on whether native DHRS9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHRS9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHRS9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...